1. Home
  2. SEIC vs ICLR Comparison

SEIC vs ICLR Comparison

Compare SEIC & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SEI Investments Company

SEIC

SEI Investments Company

N/A

Current Price

$111.46

Market Cap

11.5B

Sector

Finance

ML Signal

N/A

Logo ICON plc

ICLR

ICON plc

HOLD

Current Price

$163.58

Market Cap

9.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SEIC
ICLR
Founded
1968
1990
Country
United States
Ireland
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Commercial Physical & Biological Resarch
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.5B
9.3B
IPO Year
1995
2001

Fundamental Metrics

Financial Performance
Metric
SEIC
ICLR
Price
$111.46
$163.58
Analyst Decision
Buy
Buy
Analyst Count
7
13
Target Price
$104.86
$178.62
AVG Volume (30 Days)
569.5K
488.0K
Earning Date
04-22-2026
05-12-2026
Dividend Yield
1.14%
N/A
EPS Growth
27.66
N/A
EPS
2.99
N/A
Revenue
$2,297,381,000.00
N/A
Revenue This Year
$14.61
N/A
Revenue Next Year
$7.25
N/A
P/E Ratio
$36.50
$12.91
Revenue Growth
8.10
N/A
52 Week Low
$75.08
$66.57
52 Week High
$112.15
$203.91

Technical Indicators

Market Signals
Indicator
SEIC
ICLR
Relative Strength Index (RSI) 68.83 44.32
Support Level $86.62 $162.06
Resistance Level N/A $183.11
Average True Range (ATR) 1.60 6.33
MACD -0.28 -1.27
Stochastic Oscillator 81.85 15.88

Price Performance

Historical Comparison
SEIC
ICLR

About SEIC SEI Investments Company

SEI Investments provides investment processing, management, and operations services to financial institutions, asset managers, asset owners, and financial advisors in four material segments: private banks, investment advisors, institutional investors, and investment managers. SEI also has a minority interest in LSV Asset Management, a value equity asset manager with about $99 billion in assets under management. As of December 2025, SEI (including LSV) manages, administers, or advises about $1.9 trillion in assets.

About ICLR ICON plc

Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.

Share on Social Networks: